Cardiovascular Disease in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. 

While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel 

• Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell 

• Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard 

• Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch 

This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. 

https://attd.kenes.com